References

Alberg, Anthony J, Donald R Shopland, and K Michael Cummings. 2014. The 2014 Surgeon General’s report: commemorating the 50th Anniversary of the 1964 Report of the Advisory Committee to the US Surgeon General and updating the evidence on the health consequences of cigarette smoking. American Journal of Epidemiology 179 (4): 403–12.
Al-Hajj, Muhammad, Max S Wicha, Adalberto Benito-Hernandez, Sean J Morrison, and Michael F Clarke. 2003. “Prospective Identification of Tumorigenic Breast Cancer Cells.” Proc Natl Acad Sci U S A 100 (7): 3983–88. https://doi.org/10.1073/pnas.0530291100.
Batlle, Eduard, and Hans Clevers. 2017. “Cancer Stem Cells Revisited.” Nat Med 23 (10): 1124–34. https://doi.org/10.1038/nm.4409.
Binder, Michaela, Charlotte Roberts, Neal Spencer, Daniel Antoine, and Caroline Cartwright. 2014. “On the Antiquity of Cancer: Evidence for Metastatic Carcinoma in a Young Man from Ancient Nubia (c. 1200bc).” Edited by Michael D. Petraglia. PLoS ONE 9 (3): e90924. https://doi.org/10.1371/journal.pone.0090924.
Cancer Tomorrow. 2018. Global Cancer Observatory. http://gco.iarc.fr/tomorrow/home.
Collaborative Group on Hormonal Factors in Breast Cancer. 2019. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. Lancet (London, England) 394 (10204): 1159–68.
Data and Statistics for Health Professionals. 2018. Cancer Research UK. https://www.cancerresearchuk.org/health-professional/cancer-statistics.
Doll, R, and A B Hill. 1950. Smoking and carcinoma of the lung; preliminary report. British Medical Journal 2 (4682): 739–48.
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Davies, C, Godwin, J, Gray, R, Clarke, M, Cutter, D, Darby, S, et al. 2011. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 378 (9793): 771–84.
Farrell, A, E Hutchinsin, and B et al. Marte. 2006. Nature milestones in cancer.” Nature.
Fearon, E R, and B Vogelstein. 1990. A genetic model for colorectal tumorigenesis. Cell 61 (5): 759–67.
Ferlay, J, I Soerjomataram, M Ervik, R Dikshit, and S Eser. 2019. GLOBOCAN 2012 v1. 0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [online]. International Agency for Research on Cancer .” https://gco.iarc.fr.
Fulawka, Lukasz, Piotr Donizy, and Agnieszka Halon. 2014. Cancer stem cells the current status of an old concept: literature review and clinical approaches.” Biological Research 47 (1): 66–69.
Gerlinger, Marco, Andrew J Rowan, and et al Horswell. 2012. Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing.” The New England Journal of Medicine 366 (10): 883–92.
Grange, J M, JL Stanford, and C Stanford. 2002. Campbell De Morgan’s ’Observations on cancer’, and their relevance today.” Journal of the Royal Society of Medicine 95 (6): 296–99.
Greenwood, Emma. 2006. “From Hens to Eternity.” Nature Reviews Cancer 6 (S1): S9–9. https://doi.org/10.1038/nrc1846.
Hanahan, Douglas, and Robert A Weinberg. 2011. Hallmarks of cancer: the next generation. Cell 144 (5): 646–74.
Hanahan, D, and R A Weinberg. 2000. The hallmarks of cancer. Cell 100 (1): 57–70.
Hart, I R, and I J Fidler. 1980. Role of organ selectivity in the determination of metastatic patterns of b16 melanoma.” Cancer Research 40 (7): 2281–87.
Ilic, Dragan, Mia Djulbegovic, Jae Hung Jung, Eu Chang Hwang, Qi Zhou, Anne Cleves, Thomas Agoritsas, and Philipp Dahm. 2018. Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis. BMJ (Clinical Research Ed.) 362 (September): k3519.
Knudson, A G. 2001. Two genetic hits (more or less) to cancer. Nature Reviews Cancer 1 (2): 157–62. https://doi.org/10.1038/35101031.
Nitiss, John L. 2009. DNA topoisomerase II and its growing repertoire of biological functions. Nature Reviews Cancer 9 (5): 327–37.
Nordling, C O. 1953. A new theory on cancer-inducing mechanism. British Journal of Cancer 7 (1): 68–72.
Nowell, P C. 1976. The clonal evolution of tumor cell populations. Science 194 (4260): 23–28.
Paget, Stephen. 1889. The distribution of secondary growths in cancer of the breast.” The Lancet 133 (March): 571–73.
Pereira, Bernard, Suet-Feung Chin, Oscar M Rueda, Hans-Kristian Moen Vollan, Elena Provenzano, Helen A Bardwell, Michelle Pugh, et al. 2016. “The Somatic Mutation Profiles of 2,433 Breast Cancers Refines Their Genomic and Transcriptomic Landscapes.” Nat Commun 7 (May): 11479. https://doi.org/10.1038/ncomms11479.
Pistelli, M, A Della Mora, Z Ballatore, and R Berardi. 2018. “Aromatase Inhibitors in Premenopausal Women with Breast Cancer: The State of the Art and Future Prospects.” Curr Oncol 25 (2): e168–75. https://doi.org/10.3747/co.25.3735.
Satzinger, Helga. 2008. “Theodor and Marcella Boveri: Chromosomes and Cytoplasm in Heredity and Development.” Nat Rev Genet 9 (3): 231–38. https://doi.org/10.1038/nrg2311.
Sudhakar, Akulapalli. 2009. History of Cancer, Ancient and Modern Treatment Methods. J Cancer Sci Ther 1 (2): 1–4.
Sun, Yu, Judith Campisi, Celestia Higano, Tomasz M Beer, Peggy Porter, Ilsa Coleman, Lawrence True, and Peter S Nelson. 2012. “Treatment-Induced Damage to the Tumor Microenvironment Promotes Prostate Cancer Therapy Resistance Through Wnt16b.” Nat Med 18 (9): 1359–68. https://doi.org/10.1038/nm.2890.
Vogelstein, Bert, and Kenneth W Kinzler. 2015. “The Path to Cancer –Three Strikes and You’re Out.” N Engl J Med 373 (20): 1895–98. https://doi.org/10.1056/NEJMp1508811.
Wei, Yanchang, Heide Schatten, and Qing-Yuan Sun. 2015. “Environmental Epigenetic Inheritance Through Gametes and Implications for Human Reproduction.” Hum Reprod Update 21 (2): 194–208. https://doi.org/10.1093/humupd/dmu061.
Wong, Eric. 2012. Cancer Tomorrow. MacMasters Pathophysiology Review. http://www.pathophys.org/breast-cancer/breastcancer-copy/.